Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nimesulide-induced acute hepatitis.

W Sbeit1, N Krivoy, M Shiller

  • 1Department of Gastroenterology, Nahariya Hospital, B. Rappaport Faculty of Medicine, Technion, Israel. reshgs@naharia.health.gov.il

The Annals of Pharmacotherapy
|September 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher Short- and Long-Term Fluent Reading Abilities Following an Executive Functions-Based Reading Intervention Are Moderated by Executive Functions Improvement in Children With Reading Difficulties.

Dyslexia (Chichester, England)·2025
Same author

Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: a Big Data analysis of the World Health Organization VigiBase.

European review for medical and pharmacological sciences·2021
Same author

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.

Familial cancer·2021
Same author

Stroke symptoms impact on mental and physical health: A Lebanese population based study.

Revue neurologique·2020
Same author

Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea.

QJM : monthly journal of the Association of Physicians·2019
Same author

GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.

Bone marrow transplantation·2016
Same journal

Prolonged Response to Nivolumab in Metastatic Vulvar Carcinoma: Should Immunotherapy be Continued and for How Long? A Debatable Issue!

The Annals of pharmacotherapy·2026
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
See all related articles

Nimesulide, a nonsteroidal anti-inflammatory drug (NSAID), can cause acute hepatitis. This case study confirms nimesulide-induced liver injury through biopsy and in vitro testing, emphasizing the need for monitoring.

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver injury (DILI) is a significant clinical concern.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, contributing to DILI cases.
  • Nimesulide, a selective cyclooxygenase-2 inhibitor NSAID, is prevalent in Europe and associated with potential liver toxicity.

Purpose of the Study:

  • To document a case of acute hepatitis attributed to nimesulide.
  • To confirm the etiological role of nimesulide using histological and in vitro methods.
  • To highlight the clinical implications of nimesulide-induced hepatotoxicity.

Main Methods:

  • A 54-year-old woman presented with acute hepatitis.
  • Liver biopsy confirmed hepatitis.

Related Experiment Videos

  • An in vitro lymphocyte toxicity assay was performed to link nimesulide to the liver injury.

    • Main Results:

    • The patient's acute hepatitis was histologically confirmed.
    • Liver function tests normalized within one month after discontinuing nimesulide.
    • In vitro assay demonstrated nimesulide's direct toxicity to lymphocytes.

    Conclusions:

    • Nimesulide can induce acute hepatitis, as evidenced by biopsy and in vitro findings.
    • While NSAID-induced liver damage is uncommon, widespread use makes them a notable cause.
    • Discontinuation of nimesulide is crucial for recovery, underscoring the importance of monitoring liver function during therapy.